Quality of Life Research

, Volume 24, Issue 10, pp 2397–2402 | Cite as

Psychometric properties of Functional Assessment of Cancer Therapy-Prostate (FACT-P) in Chinese patients with prostate cancer

  • Carlos K. H. Wong
  • Edmond P. H. Choi
  • James H. L. Tsu
  • Brian S. H. Ho
  • Ada T. L. Ng
  • W. Y. Chin
  • M. K. Yiu
Brief Communication



The aim of the study was to assess the validity, reliability and sensitivity of the FACT-P (version 4) in Chinese males with prostate cancer.


Construct validity was assessed using Spearman’s correlation test against the 12-item Short Form Health Survey (SF-12v2). Internal consistency and test–retest reliability were assessed using Cronbach’s α coefficient and intra-class correlation coefficient, respectively. Sensitivity was determined by performing known-group comparisons by independent t test.


FACT-P subscale scores had a moderate correlation with the corresponding SF-12v2 domain score that conceptually measures the similar construct providing evidence for adequate construct validity. Internal consistency was acceptable (α: 0.687–0.900) for all subscales aside from the Prostate Cancer Subscale (α: 0.505) and Trial Outcome Index (α: 0.562). FACT-P subscale and total scores showed good test–retest reliability (range 0.753–0.913). All total scales and most of the subscales were sensitive in detecting differences between patients with different levels of functional impairment but not different cancer stages or levels of prostate-specific antigen.


The measure is a valid and reliable measure to assess the health-related quality of life of Chinese males with prostate cancer. The FACT-P is sensitive to detect difference between patients with varying functional status.


Quality of life Psychometrics Validity Reliability Prostate cancer Chinese 



The authors wish to express their gratitude to Professor Cindy Lam for design and planning of this study, Charles Wong for his assistance in data collection and Anca Chan for his help in performing statistical analyses.

Ethical standard

Ethics approval of the study protocol was obtained from the Institutional Review Board of the University of Hong Kong and Hospital Authority (Ref No.: UW13-239).


  1. 1.
    Ferlay, J., Shin, H. R., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer, 127(12), 2893–2917.CrossRefGoogle Scholar
  2. 2.
    Sanda, M. G., Dunn, R. L., Michalski, J., Sandler, H. M., Northouse, L., Hembroff, L., et al. (2008). Quality of life and satisfaction with outcome among prostate-cancer survivors. New England Journal of Medicine, 358(12), 1250–1261.CrossRefPubMedGoogle Scholar
  3. 3.
    Miller, D. C., Sanda, M. G., Dunn, R. L., Montie, J. E., Pimentel, H., Sandler, H. M., et al. (2005). Long-term outcomes among localized prostate cancer survivors: Health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy. Journal of Clinical Oncology, 23(12), 2772–2780.CrossRefPubMedGoogle Scholar
  4. 4.
    Litwin, M. S., Hays, R. D., Fink, A., Ganz, P. A., Leake, B., Leach, G. E., et al. (1995). Quality-of-life outcomes in men treated for localized prostate cancer. JAMA, 273(2), 129–135.CrossRefPubMedGoogle Scholar
  5. 5.
    Schmidt, S., Garin, O., Pardo, Y., Valderas, J., Alonso, J., Rebollo, P., et al. (2014). Assessing quality of life in patients with prostate cancer: A systematic and standardized comparison of available instruments. Quality of Life Research, 23(8), 2169–2181.PubMedCentralCrossRefPubMedGoogle Scholar
  6. 6.
    Cella, D. F., Tulsky, D. S., Gray, G., Sarafian, B., Linn, E., Bonomi, A., et al. (1993). The Functional Assessment of Cancer Therapy scale: Development and validation of the general measure. Journal of Clinical Oncology, 11(3), 570–579.PubMedGoogle Scholar
  7. 7.
    Overcash, J., Extermann, M., Parr, J., Perry, J., & Balducci, L. (2001). Validity and reliability of the FACT-G scale for use in the older person with cancer. American Journal of Clinical Oncology, 24(6), 591–596.CrossRefPubMedGoogle Scholar
  8. 8.
    Webster, K., Cella, D., & Yost, K. (2003). The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: Properties, applications, and interpretation. Health and quality of life outcomes, 1, 79.PubMedCentralCrossRefPubMedGoogle Scholar
  9. 9.
    Winstead-Fry, P., & Schultz, A. (1997). Psychometric analysis of the Functional Assessment of Cancer Therapy-General (FACT-G) scale in a rural sample. Cancer, 79(12), 2446–2452.CrossRefPubMedGoogle Scholar
  10. 10.
    Esper, P., Hampton, J. N., Smith, D. C., & Pienta, K. J. (1999). Quality-of-life evaluation in patients receiving treatment for advanced prostate cancer. Oncology nursing forum, 26(1), 107–112.PubMedGoogle Scholar
  11. 11.
    Esper, P., Mo, F., Chodak, G., Sinner, M., Cella, D., & Pienta, K. J. (1997). Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument. Urology, 50(6), 920–928.CrossRefPubMedGoogle Scholar
  12. 12.
    Schag, C. C., Heinrich, R. L., & Ganz, P. (1984). Karnofsky performance status revisited: Reliability, validity, and guidelines. Journal of Clinical Oncology, 2(3), 187–193.PubMedGoogle Scholar
  13. 13.
    Yu, C. L. M., Fielding, R., Chan, C. L. W., Tse, V. K. C., Choi, P. H. K., Lau, W. H., Choy, D. T. K., Lee, A. W. M., & Sham, J. S. T. (2000). Measuring quality of life of Chinese cancer patients. Cancer, 88(7), 1715–1727. Google Scholar
  14. 14.
    Wong, C. K. H., Lam, C. L. K., Law, W. L., Poon, J. T. C., Chan, P., Kwong, D. L. W., & Tsang, J. (2012). Validity and reliability study on traditional Chinese FACT-C in Chinese patients with colorectal neoplasm. Journal of Evaluation in Clinical Practice, 18(6), 1186–1195.Google Scholar
  15. 15.
    Lam, C. L. K., Wong, C. K. H., Lam, E. T. P., Lo, Y. Y. C., & Huang, W. W. (2010). Population norm of Chinese (HK) SF-12 health survey_version 2 of Chinese adults in Hong Kong. Hong Kong Practitioner, 32, 77–86.Google Scholar
  16. 16.
    Lam, C. L., Tse, E. Y., & Gandek, B. (2005). Is the standard SF-12 health survey valid and equivalent for a Chinese population? Quality of life Research, 14(2), 539–547.CrossRefPubMedGoogle Scholar
  17. 17.
    Nunnally, J. C. (1978). Psychometric theory. New York: McGraw-Hill.Google Scholar
  18. 18.
    Terwee, C. B., Bot, S. D., de Boer, M. R., van der Windt, D. A., Knol, D. L., Dekker, J., et al. (2007). Quality criteria were proposed for measurement properties of health status questionnaires. Journal of Clinical Epidemiology, 60(1), 34–42.CrossRefPubMedGoogle Scholar
  19. 19.
    Churchill, G. A., Jr. (1979). A paradigm for developing better measures of marketing constructs. Journal of marketing research, 16(1), 64–73.Google Scholar
  20. 20.
    Zhou, H. J., So, J. B., Yong, W. P., Luo, N., Zhu, F., Naidoo, N., et al. (2012). Validation of the functional assessment of cancer therapy-gastric module for the Chinese population. Health and Quality of Life Outcomes, 10, 145.PubMedCentralCrossRefPubMedGoogle Scholar
  21. 21.
    Schag, C. A., Ganz, P. A., Wing, D. S., Sim, M. S., & Lee, J. J. (1994). Quality of life in adult survivors of lung, colon and prostate cancer. Quality of Life Research, 3(2), 127–141.CrossRefPubMedGoogle Scholar
  22. 22.
    Alibhai, S. M., Breunis, H., Timilshina, N., Johnston, C., Tomlinson, G., Tannock, I., et al. (2010). Impact of androgen-deprivation therapy on physical function and quality of life in men with nonmetastatic prostate cancer. Journal of Clinical Oncology, 28(34), 5038–5045.CrossRefPubMedGoogle Scholar
  23. 23.
    Galvao, D. A., Taaffe, D. R., Spry, N., Joseph, D., Turner, D., & Newton, R. U. (2009). Reduced muscle strength and functional performance in men with prostate cancer undergoing androgen suppression: A comprehensive cross-sectional investigation. Prostate Cancer and Prostatic Diseases, 12(2), 198–203.CrossRefPubMedGoogle Scholar
  24. 24.
    Storer, T. W., Miciek, R., & Travison, T. G. (2012). Muscle function, physical performance and body composition changes in men with prostate cancer undergoing androgen deprivation therapy. Asian Journal of Andrology, 14(2), 204–221.PubMedCentralCrossRefPubMedGoogle Scholar
  25. 25.
    Chie, W.-C., Yu, C.-C., & Yu, H.-J. (2010). Reliability and validity of the Taiwan Chinese version of the EORTC QLQ-PR25 in assessing quality of life of prostate cancer patients. Urological Science, 21(3), 118–125.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2015

Authors and Affiliations

  • Carlos K. H. Wong
    • 1
  • Edmond P. H. Choi
    • 1
  • James H. L. Tsu
    • 2
  • Brian S. H. Ho
    • 2
  • Ada T. L. Ng
    • 2
  • W. Y. Chin
    • 1
  • M. K. Yiu
    • 2
  1. 1.Department of Family Medicine and Primary CareUniversity of Hong KongAp Lei ChauHong Kong
  2. 2.Division of Urology, Department of SurgeryUniversity of Hong KongPokfulamHong Kong

Personalised recommendations